Aventyn Inc., an innovative provider of secure connected clinical information processing solutions, launched healthKrypt™, patent pending technology for securing health information and trusted transaction processing. This announcement was made jointly at HIMMS in Atlanta, GA and RSA2010 in San Francisco, CA.
“The security framework for healthKrypt is built to execute security functions in a processor using known processor architectural constructs with minimal performance impact”
healthKrypt is simple, low encryption/bit cost and easy to implement multi factor security technology that works on multiple platforms, virtualization layers, cloud data and portals. Now it is possible to encrypt user ID, software applications and data using dynamic encryption algorithm that is specific to the user, device, content and service combination. By uniquely encrypting user IDs, devices and data, health record information is protected with one-click authentication and robust key management. Secure user profile-based accesses to provider, payer, and consumer portals provide CIO’s capability to offer new value-add services, extend and improve secure trusted partner transactions preventing theft and fraud.
“The security framework for healthKrypt is built to execute security functions in a processor using known processor architectural constructs with minimal performance impact,” said Bhaktha Ram, CTO at Aventyn. “The custom security algorithms are software, user and device platform specific; protect against software vulnerabilities, prevent ID theft, fraud and class break scenario.” healthKrypt is deployed in real-time as a lightweight “driver” for securely executing code and retrieving secure data on existing standard x86 and ARM hardware and software platforms without additional requirements for security hardware and software.
Health IT and Medical Banking systems are further strengthened with custom work-flow using processor specific security features with *Intel x86 AMT/VT/TXT, AMD-V and ARM TrustZone technologies for scalability.
No comments:
Post a Comment